Dose curve [PK / PD]

posted by Sundar.M – India, 2019-02-15 13:37 (974 d 09:09 ago) – Posting: # 19925
Views: 1,264

Dear all,

How to choose dose for any PK/PD study (without non-clinical data) in healthy volunteer for Phase-1 trials for already marketed product? Other words, how to choose the proposed dose to detect clinically meaningful differences in PK/PD responses?

Thanks for your help.

Thanks
MSMN

Complete thread:

Activity
 Admin contact
21,729 posts in 4,543 threads, 1,543 registered users;
online 3 (0 registered, 3 guests [including 3 identified bots]).
Forum time: Saturday 23:47 CEST (Europe/Vienna)

If you want to converse with me,
define your terms.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5